About
A few words About us
——
Nanjing Kangyi Medical Apparatus Co., Ltd. is an innovative medical technology enterprise deeply engaged in medical device R&D, core technology transformation, and digital operation services. With independent technological innovation as the core and clinical safety compliance as the bottom line, the company focuses on creating integrated solutions covering the full lifecycle management of cardiac pacemakers and the full-process digital control of high-value medical consumables, thereby facilitating the upgrade of China's medical device industry towards miniaturization, intelligence, digitalization, and high quality.
Company Introduction
Relying on core technologies from independently developed software copyrights, Nanjing Kangyi Medical Apparatus Co., Ltd. precisely addresses industry pain points such as inaccurate temperature and humidity control, weak supply chain sterility assurance, extensive inventory and expiry date management, lagging postoperative data tracking, and dependence on imports for core components. It has established a complete technical system covering full-process medical device management, core control of cardiac pacemakers, and postoperative monitoring and follow-up.
The company's technologies and products have been widely adopted by leading pharmaceutical distribution enterprises, renowned medical device manufacturers, tertiary Grade A hospitals, and authoritative research institutions and universities across China. It has established in-depth collaborations with industry leaders such as Shanghai Pharma, Medtronic, Demax, Beijing AK Medical, and Mindray. Its technological achievements have been highly recognized by authoritative institutions and top universities, including MicroPort Soaring CRM, the Chinese Society of Biomedical Engineering, Renmin Hospital of Wuhan University, West China Hospital, Sichuan University, the University of Chinese Academy of Sciences, and Fudan University, maintaining a leading position in both market coverage and industry influence.
Over the years, the company has established a high-quality multidisciplinary team integrating R&D, clinical practice, management, and operations, ensuring safe and efficient product implementation through standardized management, regulated processes, and full-lifecycle services. Leveraging its outstanding innovation capabilities, the company has successively received numerous authoritative honors, including the 2020 i-Awards - Innovative Enterprise in Healthcare, the Best Solution in the "Patient Service" Field in the 2022 Healthy China Action Demonstration V Innovation Industry List, the TOP 100 Most Innovative Medical Technology Products (Solutions) of 2022, and the 2023 China Software Technology Conference Leading Enterprise Award. It has become a benchmark enterprise in the field of digital management of cardiac pacemakers and high-value medical consumables in China.
In the future, Kangyi Medical Apparatus will continue to uphold its original aspiration of technological independence, quality first, and clinical service, continuously iterating its core technologies and solutions. The company will deepen its engagement in the innovative R&D of cardiac pacemakers and the digital track for high-value medical consumables, constantly breaking foreign technological monopolies and addressing management deficiencies in the industry. Joining hands with partners, the company will promote the higher-level independent controllability and high-quality development of China's medical device industry, contributing professional strength to safeguarding national health and supporting the construction of a Healthy China.